GASTRIC RETENTIVE EXTENDED RELEASE PHARMACEUTICAL COMPOSITIONS
    3.
    发明申请
    GASTRIC RETENTIVE EXTENDED RELEASE PHARMACEUTICAL COMPOSITIONS 审中-公开
    胃肠强力扩展药物组合物

    公开(公告)号:US20160243041A1

    公开(公告)日:2016-08-25

    申请号:US15147621

    申请日:2016-05-05

    申请人: MALLINCKRODT LLC

    摘要: The present disclosure provides extended release pharmaceutical compositions comprising an opioid and an additional active pharmaceutical ingredient, wherein the composition exhibits gastric retentive properties which are achieved by a combination of a physical property of the composition and release of the opioid, wherein upon administration to a subject, the composition has at least one pharmacokinetic parameter that differs by less than about 30% when the subject is in a fasted state as compared to a fed state.

    摘要翻译: 本公开提供了包含阿片样物质和另外的活性药物成分的延长释放药物组合物,其中所述组合物显示出通过组合物的物理性质和阿片样物质的释放的组合来实现的胃保持性质,其中在施用于受试者 当与进食状态相比,当受试者处于禁食状态时,该组合物具有至少一个药代动力学参数差异小于约30%。

    GASTRIC RETENTIVE EXTENDED RELEASE PHARMACEUTICAL COMPOSITIONS
    6.
    发明申请
    GASTRIC RETENTIVE EXTENDED RELEASE PHARMACEUTICAL COMPOSITIONS 有权
    胃肠强力扩展药物组合物

    公开(公告)号:US20140105977A1

    公开(公告)日:2014-04-17

    申请号:US14132500

    申请日:2013-12-18

    申请人: MALLINCKRODT LLC

    摘要: The present disclosure provides extended release pharmaceutical compositions comprising an opioid and an additional active pharmaceutical ingredient, wherein the composition exhibits gastric retentive properties which are achieved by a combination of a physical property of the composition and release of the opioid, wherein upon administration to a subject, the composition has at least one pharmacokinetic parameter that differs by less than about 30% when the subject is in a fasted state as compared to a fed state.

    摘要翻译: 本公开提供了包含阿片样物质和另外的活性药物成分的延长释放药物组合物,其中所述组合物显示出通过组合物的物理性质和阿片样物质的释放的组合来实现的胃保持性质,其中在施用于受试者 当与进食状态相比,当受试者处于禁食状态时,该组合物具有至少一个药代动力学参数差异小于约30%。